IJMS | Free Full-Text | The Mechanism-Based Inactivation of CYP3A4 by Ritonavir: What Mechanism?
Experimental COVID-19 Therapy Combination Lopinavir/Ritonavir Is Implicated in a Complicated Set of Drug-Drug Interactions - Anesthesia Patient Safety Foundation
Lopinavir-ritonavir does not suppress SARS-CoV-2 activity in vitro
High rate of major drug–drug interactions of lopinavir–ritonavir for COVID-19 treatment | Scientific Reports
Ritonavir (Norvir)
Dual therapy with ritonavir-boosted protease inhibitor (PI) plus lamivudine versus triple therapy with ritonavir-boosted PI plus two nucleos(t)ide reverse-transcriptase inhibitor in HIV-infected patients with viral suppression - ScienceDirect
Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based Regimens | PLOS ONE
What Is Lopinavir and Ritonavir Combination Therapy?
HIV-Protease Inhibitors: Viral Resistance, Pharmacokinetic Boosting, and Medication Adherence
Ritonavir - Wikipedia
Ritonavir Tablets: Package Insert - Drugs.com
Ritonavir boosting of low-dose danoprevir (RG7227; ITMN-191), HCV NS3/4A protease inhibitor, results in robust reduction in HCV RNA at lower exposures than provided by unboosted regimens
Switch to RPV-TDF-FTC from Ritonavir-boosted PI Regimen SPIRIT STUDY - ppt download
Lopinavir–ritonavir super-boosting in young HIV-infected children on rifampicin-based tuberculosis therapy compared with lopinavir–ritonavir without rifampicin: a pharmacokinetic modelling and clinical study - The Lancet HIV
IJMS | Free Full-Text | The Mechanism-Based Inactivation of CYP3A4 by Ritonavir: What Mechanism?
Improvement in Bioavailability and Pharmacokinetic Characteristics of Efavirenz with Booster Dose of Ritonavir in PEGylated PAMAM G4 Dendrimers | SpringerLink
Structures of the boosters (CYP inhibitors) ritonavir and cobicistat,... | Download Scientific Diagram
Ritonavir boosting of low-dose danoprevir (RG7227; ITMN-191), HCV NS3/4A protease inhibitor, results in robust reduction in HCV RNA at lower exposures than provided by unboosted regimens
Trial profile. DTG, dolutegravir; PI/r, ritonavir-boosted protease... | Download Scientific Diagram
HIV-Protease Inhibitors: Viral Resistance, Pharmacokinetic Boosting, and Medication Adherence
Biomedicines | Free Full-Text | Management of Antiretroviral Therapy with Boosted Protease Inhibitors—Darunavir/Ritonavir or Darunavir/Cobicistat
Adrenal insufficiency due to ritonavir-triamcinolone drug–drug interaction without preceding Cushing's syndrome - S Noe, H Jaeger, S Heldwein, 2018
Paxlovid (nirmatrelvir and ritonavir) for the Treatment of Covid-19
How Ritonavir acts as booster drug - YouTube
HIV Antiretroviral Pharmacokinetic Boosters - Ritonavir ... | GrepMed
